Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?

Our recent studies have suggested that prostate tumor invasion is triggered by autoimmunoreactions induced focal basal cell layer disruptions (FBCLD) that selectively favor monoclonal proliferation of the overlying progenitors or of a biologically more aggressive cell clone. As circulating chromogranin-A (CgA) levels are found to correlate with tumor progression and the status of hormone refractoriness, our current study attempted to assess whether CgA-positive cells would be preferentially distributed in epithelial structures with FBCLD. Paraffin-embedded specimens from 50 patients with organ-confined prostate cancer were subjected to double immunohistochemical analysis with monoclonal antibodies to basal cells and CgA. From each case, 3-5 randomly selected fields were digitally photographed and the photos were magnified 400% and the numbers of CgA-positive cells in epithelial structures with non-disrupted, focally disrupted, and lost basal cell layer were separately counted. The averaged number of cell for each category was statistically compared with the Pearson's Chi-square test. In addition, morphologically similar structures with and without CgA-positive cell clusters were microdissected from four selected cases and subjected to a comparison of differential micro-RNA expression levels. Our study revealed that, although isolated CgA-positive cells were seen in both the basal cell layer and the luminal cell population in all cases, only 8 cases (16%) harbored large clusters of CgA-positive cells that were concentrated in a given area, in which all or nearly all cells appeared to share a similar morphological and immunohistochemical profile. Microdissected epithelial structures with CgA-positive cell clusters exhibited a more than 5- and 7-fold lower expression of miR-146a and miR-146b-5p than their CgA-negative counterparts. As focal basal cell layer disruptions and the reduction or loss of miR-146a and miR-146b-5p has been documented to correlate with prostate tumor invasion and hormone refractoriness, our findings suggest that aberrant CgA expression in epithelial structures with FBCLD may represent an early sign of these events.

[1]  N. Normanno,et al.  Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV‐Cripto‐1 transgenic mice , 2004, Journal of cellular physiology.

[2]  T. Boulikas,et al.  Phosphorylation of transcription factors and control of the cell cycle. , 1995, Critical reviews in eukaryotic gene expression.

[3]  N. Polissar,et al.  Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Kenya Yamaguchi,et al.  Implications of circulating chromogranin A in prostate cancer , 2007, Scandinavian journal of urology and nephrology.

[5]  H. Bonkhoff,et al.  Basement membranes in fetal, adult normal, hyperplastic and neoplastic human prostate , 2005, Virchows Archiv A.

[6]  Donald C. Chang,et al.  Loss of mir-146a function in hormone-refractory prostate cancer. , 2008, RNA.

[7]  Ming Tan,et al.  ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. , 2006, Cancer research.

[8]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[9]  B. Norlén,et al.  Clinical Management of Premalignant Lesions of the Prostate , 2000, Scandinavian journal of urology and nephrology. Supplementum.

[10]  T. Wheeler,et al.  A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Fletcher,et al.  Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. , 2005, American journal of clinical pathology.

[12]  R Montironi,et al.  p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.

[13]  Y. Man,et al.  Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion. , 2005, Cancer detection and prevention.

[14]  M. Webber,et al.  Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  K. Żukowski,et al.  Degradation of basement membrane by prostate tumor heparanase. , 1999, The Journal of surgical research.

[16]  W. A. Gardner,et al.  Atrophy and proliferation in the young adult prostate. , 1987, The Journal of urology.

[17]  S. Artavanis-Tsakonas,et al.  Notch: the past, the present, and the future. , 2010, Current topics in developmental biology.

[18]  Rafael A Irizarry,et al.  Processing of Agilent microRNA array data , 2010, BMC Research Notes.

[19]  A. Verstraeten,et al.  Tenascin expression in basal cell carcinoma , 1992, The British journal of dermatology.

[20]  N. Goldstein,et al.  Cytokeratin 34βE-12 immunoreactivity in benign prostatic acini : Quantitation, pattern assessment, and electron microscopic study , 1999 .

[21]  G P Siegal,et al.  Loss of basement membrane components by invasive tumors but not by their benign counterparts. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[22]  M. Cerruto,et al.  The possible role of chromogranin A as a prognostic factor in organ-confined prostate cancer. , 2005, The International journal of biological markers.

[23]  Wei Zhang,et al.  A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo , 2010, The Prostate.

[24]  F. Abbas,et al.  Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer , 2008, BMC urology.

[25]  W. A. Gardner,et al.  Embryonal hyperplasia of the prostate , 1986 .

[26]  J. Hoying,et al.  HER2/neu over‐expression induces endothelial cell retraction , 2001, International journal of cancer.

[27]  M. Villaronga,et al.  Notch signaling: a potential therapeutic target in prostate cancer. , 2008, Current cancer drug targets.

[28]  T. Boulikas Control of DNA replication by protein phosphorylation. , 1994, Anticancer research.

[29]  Chengquan Zhao,et al.  A subset of prostate basal cells lacks the expression of corresponding phenotypic markers. , 2006, Pathology, research and practice.

[30]  Y. Doki,et al.  Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy , 2009, Cancer.

[31]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[32]  Yusuke Nakamura,et al.  Molecular Features of the Transition from Prostatic Intraepithelial Neoplasia (PIN) to Prostate Cancer , 2004, Cancer Research.

[33]  M. Webber,et al.  Intercellular Communication and Human Prostate Carcinogenesis , 2002, Annals of the New York Academy of Sciences.

[34]  Z. Qu Immunohistological detection of growth factors and cytokines in tissue mast cells. , 2006, Methods in molecular biology.

[35]  A. Mills,et al.  Role of p63 and basal cells in the prostate , 2004, Development.

[36]  D. Bostwick Prostatic intraepithelial neoplasia is a risk factor for cancer. , 1999, Seminars in urologic oncology.

[37]  J. O’Sullivan,et al.  Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer , 2009, The American journal of surgical pathology.

[38]  J. Oesterling,et al.  The Relationship Between Prostatic Intraepithelial Neoplasia and Prostate Cancer: Critical Issues , 1997 .

[39]  W. A. Gardner,et al.  Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. , 2008, Medical hypotheses.

[40]  S. Tretli,et al.  Is prostatic intraepithelial neoplasia in the transition/central zone a true precursor of cancer? A long-term retrospective study in Norway. , 1998, British Journal of Cancer.

[41]  K. Tsubota,et al.  Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2. , 2005, Investigative ophthalmology & visual science.

[42]  Y. Nishiwaki,et al.  Histopathologic Features of the Tumor Budding in Adenocarcinoma of the Lung: Tumor Budding As an Index to Predict the Potential Aggressiveness , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[43]  W. Eckhart,et al.  Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells , 2006, Breast Cancer Research.

[44]  W. Isaacs,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .

[45]  H. Bonkhoff,et al.  Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model , 1996, The Prostate.

[46]  L. Holmberg,et al.  Tumour markers in breast carcinoma correlate with grade rather than with invasiveness , 2001, British Journal of Cancer.

[47]  Jerome P. Richie,et al.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.

[48]  S. Sheng,et al.  Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Wei Zhang,et al.  Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  Nadine Kabbani,et al.  Enhanced Proliferation, Survival, and Dopaminergic Differentiation of CNS Precursors in Lowered Oxygen , 2000, The Journal of Neuroscience.

[51]  L. Qi,et al.  Neuroendocrine differentiation is involved in chemoresistance induced by EGF in prostate cancer cells. , 2009, Life sciences.

[52]  Liang Chen,et al.  miRNA Biomarkers in Breast Cancer Detection and Management , 2011, Journal of Cancer.

[53]  M. Chopp,et al.  MiR-146b-5p Suppresses EGFR Expression and Reduces In Vitro Migration and Invasion of Glioma , 2010, Cancer investigation.

[54]  K. Hellström,et al.  Development of a cancer DNA phenotype prior to tumor formation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Brian Leyland-Jones,et al.  Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. , 2008, BioTechniques.

[56]  T. Roskams,et al.  Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer? , 2003, Prostate Cancer and Prostatic Diseases.

[57]  H. Bonkhoff Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[58]  T. Golde,et al.  Targeting Notch to Target Cancer Stem Cells , 2010, Clinical Cancer Research.

[59]  M. Papotti,et al.  Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease. , 2007, The Journal of urology.

[60]  John C. Doyle,et al.  Oxygen‐mediated regulation of skeletal muscle satellite cell proliferation and adipogenesis in culture , 2001, Journal of cellular physiology.

[61]  A. El-Karef,et al.  Co‐stimulation of human breast cancer cells with transforming growth factor‐β and tenascin‐C enhances matrix metalloproteinase‐9 expression and cancer cell invasion , 2004, International journal of experimental pathology.

[62]  Takashi Sato,et al.  Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. , 2004, Gynecologic oncology.

[63]  E. Jarocka-Cyrta,et al.  Mast cells in neoangiogenesis. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[64]  L. Dogliotti,et al.  Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. , 2005, Endocrine-related cancer.

[65]  R. Autorino,et al.  Neuroendocrine Immunophenotype as Predictor of Clinical Recurrence in 110 Patients with Prostate Cancer , 2007, International journal of immunopathology and pharmacology.

[66]  Y. Man,et al.  An antigen unmasking protocol that satisfies both immunohistochemistry and subsequent PCR amplification. , 2003, Pathology, research and practice.

[67]  F. Booth,et al.  Culture in low levels of oxygen enhances in vitro proliferation potential of satellite cells from old skeletal muscles , 2001, Cellular and Molecular Life Sciences (CMLS).

[68]  Donald C. Malins,et al.  A new structural analysis of DNA using statistical models of infrared spectra , 1997, Nature Medicine.

[69]  H. Bonkhoff,et al.  Morphogenese der benignen Prostatahyperplasie und des Prostatakarzinoms , 1998, Der Pathologe.

[70]  C. Stephan,et al.  MicroRNAs as regulators of signal transduction in urological tumors. , 2011, Clinical chemistry.

[71]  Roger J Daly,et al.  Increased Proliferation and Altered Growth Factor Dependence of Human Mammary Epithelial Cells Overexpressing the Gab2 Docking Protein* , 2006, Journal of Biological Chemistry.

[72]  R. Nakamura Cancer diagnostics : current and future trends , 2004 .

[73]  L. Ellis,et al.  Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. , 1996, Journal of the National Cancer Institute.

[74]  D. Bostwick Prospective origins of prostate carcinoma: Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia , 1996, Cancer.

[75]  K. Leong,et al.  The Notch pathway in prostate development and cancer. , 2008, Differentiation; research in biological diversity.